His points about the name of the company and that it's non-reporting were ridiculous. As has been pointed out, he knows nothing about the crypto software so the name is perfectly fine. Maybe it was because it was hard for him to say. Not the most fluid speaker I've ever heard.
About non-reporting - many of the stocks I own are non-reporting since they want to save money. I've made a lot of money on those stocks. It's not a reason to not own a stock.
UBQU does need to be careful about their claims on their website. They are on the edge of what's permissible but if they are told by the FDA to tone it down they will make the necessary changes.
The other thing he said that was bizarre was that the CBD market is tiny and so being Forbes #5 in a tiny market isn't saying much. But it's an exponentially growing market so his point was another indication of his ignorance.